Bordeaux, 27th March 2014 BERRIES: AN INNOVATIVE HEALTHY CHOICE - - PowerPoint PPT Presentation
Bordeaux, 27th March 2014 BERRIES: AN INNOVATIVE HEALTHY CHOICE - - PowerPoint PPT Presentation
Luca Mazzoni, PhD student Universit Politecnica delle Marche Dipartimento di Scienze Cliniche, Specialistiche ed Odontostomatologiche Bordeaux, 27th March 2014 BERRIES: AN INNOVATIVE HEALTHY CHOICE Relevant biological and nutritional
Relevant biological and nutritional qualities
BERRIES: AN INNOVATIVE HEALTHY CHOICE
STRAWBERRY (Fragaria X Ananassa, Duch.)
One of the most commonly consumed berries, both in fresh and processed forms; Relevant source of bioactive compounds due to its high level of Vitamin C, folate and phenolic constituents which express relevant antioxidant capacities; The most studied berry from the agronomic, genomic and nutritional point
- f view
Anthocyanins Vitamin C Flavanols/PACs HBA HCA Flavonols Tannins Folate Vitamin E
STRAWBERRY (Fragaria x ananassa, Duch.)
Pelargonidin-3-glucoside (25-40% TAC)
STRAWBERRY QUALITY
b,c d c,d c,d a c,d a a,b b,c c b,c b a b,c a,b b,c c e d c,d f b a,b a 0.5 1 1.5 2 2.5 3 3.5 mg/g FW
TPC Flavo ACY
Total content of phenols, flavonoids and anthocyanins
a,b b a,b a,b a b a a,b c d c c a c,d a b 5 10 15 20 25 30 35 40 Alba Irma Patty Adria Sveva AN99.7851 AN94.414.52 AN00.239.55 mmol TEq/g FW
TEAC FRAP
STRAWBERRY QUALITY
Total Antioxidant capacity
- High content of
pelargonidin-3-glucoside
- Relevant total antioxidant
capacity
- High content of Vitamin C
min 10 20 30 40 50 60 mAU 250 500 750 1000 1250 1500 1750 2000
Pelargonidina-3- glucoside
UV-A treatment 275 kJ/m2 HPLC-DAD-MS analysis
Incubation for 24 hours with different concentrations of the extracts (0.5 – 0.25 – 0.05 mg/ml) DNA damage
20 40 60 80 100 120 5 10 15 20 25 30 % live cells min 0.5 mg/ml 0.25 mg/ml 0.05 mg/ml ctrl
* *
Cell viability
5 10 15 20 25 30 35 40 45 50 ctrl 0.05 mg/ml 0.25 mg/ml 0.5 mg/ml % Tail Intensity
* *
IN VITRO studies
Human dermal fibroblast - HDF
DNA damage
Cells Viability
IN VITRO studies
Human dermal fibroblast - HDF
Incubation for 24 hours with different concentrations of the extracts (0.5 – 0.25 – 0.05 mg/ml)
H2O2 treatment / 1h
H2O2 treatment / 1h
Intracellular ROS
IN VITRO studies
Human dermal fibroblast - HDF
50 100 150 200 250 300 2 4 6 8 10 F.U. mM H2O2
120 min
ctrl 0.5 mg/ml
* * **
0 0.5 1 2.5 5 10
50 100 150 200 250 300 2 4 6 8 10 F.U. mM H2O2
30 min
ctrl 0.5 mg/ml
* * **
0 0.5 1 2.5 5 10
Lipid peroxidation DNA damage
25 50 75 100 0 µM 60 µM 80 µM 100 µM % T.I. µM H2O2 control 0.5 mg/ml extract
* * *
2 4 6 8 10 12 0,37 0,74 G/R µM H2O2 ctrl 0.5 mg/ml
*
5 50 500
** **
H2O2 treatment / 1h
IN VITRO studies
Human dermal fibroblast - HDF
20.000 HuDe; stress agent H2O2 5 mM; strawberry methanolic extract applied 0.5 mg/ml; inhibitors concentration: Oligomycin 1 µg/ml, 2,4-Dinitrophenol (2-DNP) 100 µM, Rotenone 1µM
20 40 60 80 100 120 140 160 10 20 30 40 50 60 70 80 OCR (Pmoles/min) minutes
Mitochondrial respiration
Control 0.5 mg/ml
Oligomycin Rotenone 2,4-DNP
Seahorse XF-24: Mitochondrial respiration (OCR)
H2O2 treatment / 1h
IN VITRO studies
Human dermal fibroblast - HDF
Seahorse XF-24: Glycolysis (ECAR)
5 10 15 20 10 20 30 40 50 60 70 80 ECAR (mPh/min) minutes
Glycolysis
control 0.5 mg/ml
Rotenone 2 D-Glucose Glucose
20.000 HuDe; stress agent H2O2 5 mM; strawberry methanolic extract applied 0.5 mg/ml; inhibitor concentrations: Rotenone 3 µg/ml, Glucose 10 mM, 2-DeoxyGlucose (2-DG) 100mM H2O2 treatment / 1h
IN VITRO studies
Human dermal fibroblast - HDF
Cells Viability
IN VITRO studies
Human dermal fibroblast - HDF
Incubation for 24 hours with different concentrations of the extracts (0.5 – 0.25 – 0.05 mg/ml)
AAPH treatment / 1h
10 20 30 40 50 60 70 80 90 2.5 5 7.5 10 12.5 15 % live cells mM AAPH Ctrl 0.5 mg/ml
** ** ** *
Anthocyanin-rich strawberry extract protects against oxidative stress damage and improves mitochondrial functionality in human dermal fibroblasts exposed to oxidant agent.
Francesca Giampieri, José M. Alvarez-Suarez, Luca Mazzoni , Tamara Y. Forbes-Hernandez, Massimiliano Gasparrini, Ana M. Gonzàlez-Paramàs, Celestino Santos-Buelga, Josè L. Quiles, Bruno Mezzetti, and Maurizio Battino
Submitted
Lipid peroxidation
IN VITRO studies
Human dermal fibroblast - HDF
Incubation for 24 hours with different concentrations of the extracts (0.5 – 0.25 – 0.05 mg/ml)
AAPH treatment / 1h
Anthocyanin-rich strawberry extract protects against oxidative stress damage and improves mitochondrial functionality in human dermal fibroblasts exposed to oxidant agent.
Francesca Giampieri, José M. Alvarez-Suarez, Luca Mazzoni , Tamara Y. Forbes-Hernandez, Massimiliano Gasparrini, Ana M. Gonzàlez-Paramàs, Celestino Santos-Buelga, Josè L. Quiles, Bruno Mezzetti, and Maurizio Battino
Submitted
IN VITRO studies
Human dermal fibroblast - HDF
Anthocyanin-rich strawberry extract protects against oxidative stress damage and improves mitochondrial functionality in human dermal fibroblasts exposed to oxidant agent.
Francesca Giampieri, José M. Alvarez-Suarez, Luca Mazzoni , Tamara Y. Forbes-Hernandez, Massimiliano Gasparrini, Ana M. Gonzàlez-Paramàs, Celestino Santos-Buelga, Josè L. Quiles, Bruno Mezzetti, and Maurizio Battino
Submitted
Live/dead/apoptosis cells by TALI
10 20 30 40 50 60 70 80 90 Ctr 2,5 5 10 15 % cells mM AAPH Live Dead Apoptotic 10 20 30 40 50 60 70 80 90 Ctr 2,5 5 10 15 % cells mM AAPH Live Dead Apoptotic
Without strawberry With strawberry
AAPH treatment / 1h
IN VITRO studies
Human dermal fibroblast - HDF
Anthocyanin-rich strawberry extract protects against oxidative stress damage and improves mitochondrial functionality in human dermal fibroblasts exposed to oxidant agent.
Francesca Giampieri, José M. Alvarez-Suarez, Luca Mazzoni , Tamara Y. Forbes-Hernandez, Massimiliano Gasparrini, Ana M. Gonzàlez-Paramàs, Celestino Santos-Buelga, Josè L. Quiles, Bruno Mezzetti, and Maurizio Battino
Submitted
Intracellular ROS
AAPH treatment / 1h
IN VITRO studies
Human dermal fibroblast - HDF
Anthocyanin-rich strawberry extract protects against oxidative stress damage and improves mitochondrial functionality in human dermal fibroblasts exposed to oxidant agent.
Francesca Giampieri, José M. Alvarez-Suarez, Luca Mazzoni , Tamara Y. Forbes-Hernandez, Massimiliano Gasparrini, Ana M. Gonzàlez-Paramàs, Celestino Santos-Buelga, Josè L. Quiles, Bruno Mezzetti, and Maurizio Battino
Submitted
Mithocondrial respiration
AAPH treatment / 1h
20 40 60 80 100 120 140 160 180 200 5 10 15 20 25 30 pmol O2/min 5 mM AAPH Ctrl 0.5 mg/ml
Oligomyci 2-DNP Rotenon Antimycin A
20 40 60 80 100 120 140 5 10 15 20 25 30 pmol O2/min 10 mM AAPH Ctrl 0.5 mg/ml
Oligomycin 2-DNP Rotenon Antimycin A
20.000 HuDe; stress agent AAPH; strawberry methanolic extract applied 0.5 mg/ml; inhibitors concentration: Oligomycin 1 µg/ml, 2,4- Dinitrophenol (2-DNP) 100 µM, Rotenone 1µM, Antimycin A 1µM
IN VITRO VERSUS IN VIVO EVIDENCE: HOW TO BYPASS THE GAP?
In vitro effects In vivo effects
Few literature data on strawberry intake and antioxidant status
Strawberry polyphenolic extract
ETHANOL
- Widespread gastric lesion
- Oxidative Stress
ULCER INDEX SOD ACTIVITY CAT ACTIVITY
The rats daily received 40 mg/kg body weight of strawberry crude extract intragastrically using a gavage for 10 days
A B C D E A B C D E A B C D E A B C D E
HPLC-DAD- MS analysis
ON ANIMALS studies
Peak Tentative identification Adria cultivar (mg/kg) Sveva cultivar (mg/kg) 1 (Epi)afzelechin-(4→8)Pg-3-glucoside 3.798 ± 0.4 1.754 ± 0.1 2 Cy-3-glucoside 32.232 ± 2.1 25.974 ± 2.2 3 Pg 3,5-diglucoside 0.588 ± 0.0 0 ± 0.0 4 Pg 3-glucoside 1157.376 ± 12.0 790.234 ± 7.0 5 Pg 3-rutinoside 97.848 ± 4.0 26.176 ± 2.0 6 Pg 3-malonylglucoside 32.562 ± 3.0 45.62 ± 2.2 7 Pg 3-acetylglucoside 7.114 ± 4.0 3.284 ± 1.0 Total Anthocyanin Content 1331.518 ± 4.6 893.042 ± 2.3
SVEVA ADRIA ACY TAC ACY TAC
ON ANIMALS studies
16 weeks supplementation Diet with 10% strawberry
Doxorubicin
injection
2 4 6 8 10 12 14
C group C-DOX group S-DOX group A-DOX group mg/ml
α-Tocoferol
n.s.
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
C group C-DOX group S-DOX group A-DOX group mg/ml
Retinol
a c b b
SVEVA ADRIA
ON ANIMALS studies
16 weeks supplementation Diet with 10% strawberry
Doxorubicin
injection
GSHa Protein carbonyl contenta TBARSa Hydroperoxidesa C group 164.39 ± 2.54a 7.65 ± 0.23b 0.46 ± 0.16b 11.42 ± 0.04c C-DOX group 96.13 ± 1.27c 24.33 ± 2.54a 0.90 ± 0.15a 20.4 ± 0.28a A-DOX group 139.85 ± 1.04b 8.74 ± 0.93b 0.37 ± 0.06b 12.22 ± 0.37bc S-DOX group 132.67 ± 0.34b 5.71 ± 1.15b 0.42 ± 0.01b 12.96 ± 0.05b
SVEVA ADRIA
ON ANIMALS studies
16 weeks supplementation Diet with 10% strawberry
Doxorubicin
injection
GSTa GPxa GRa SODb Catalaseb C group 430.01 ± 3.95a 0.55 ± 0.04a 170.96 ± 5.75a 123.33 ± 1.81a 18.98 ± 1.52a C-DOX group 221.42 ± 27.49b 0.31 ± 0.03b 83.81 ± 4.61b 45.66 ± 0.05c 9.73 ± 0.78b A-DOX group 425.26 ± 33.43a 0.53 ± 0.07a 167.73 ± 6.02a 106.75 ± 2.68ab 19.90 ± 1.78a S-DOX group 424.02 ± 4.37a 0.52 ± 0.03a 164.13 ± 3.41a 89.18 ± 2.54b 19.40 ± 1.01a
SVEVA ADRIA
ON ANIMALS studies
16 weeks supplementation Diet with 10% strawberry
Doxorubicin
injection
2 4 6 8 10 12 14 16 18 C group C-DOX group S-DOX group A-DOX group % DNA damage c a a b
SVEVA ADRIA
ON ANIMALS studies
16 weeks supplementation Diet with 10% strawberry
Doxorubicin
injection
0,5 1 1,5 2 2,5 3 C group C-Dox group S-Dox group A-Dox group nmol DCF/mg protein a a b b
10 20 30 40 50 60 70 80 90 5 10 15 20 25 30 35 40
pmolO2/min/mgprot Time (min)
C group C-DOX group S-DOX group A-DOX group
Succinate Ascorbate + TMPD Antimycin A Rotenone
SVEVA ADRIA
ON ANIMALS studies
32 Old rats (16 month) 32 Young rats (4 month)
Standard diet (AIN93)
AIN93
Standard diet (AIN93)
AIN93
+ Strawberry
I II
Standard diet (AIN93)
AIN93
+ Fragole IV
Standard diet (AIN93)
AIN93
III
Time
Day 57 Day 58
+ Strawberry
Day 60 Sacrifice Experimental design
Doxorubicin injection
ON ANIMALS studies
(Young and old Wistar rats)
Markers Plasma
Proteic oxidation (GSH, carbonyl groups) Lipidic oxidation (TBARS Hydroperoxides) Lipidic Profile Hepatic damage Antioxidant capacity and free radical scavenging
Lymphocytes
ROS intracellular concentration
Liver
Homogenate Proteic Oxidation (GSH, carbonyl groups) Lipidic oxidation (TBARS, Hydroperoxides) Antioxidant enzymes (GPx, GR, GST, Catalase, SOD) Gene expression (Western blot) Hepatocytes ROS Intracellular concentration Mitochondria ROS intracellular concentration Mitochondrial functionability (XF- 24 extracellular flux analyzer) ATP Citrate synthase Hystopathology analysis
ON ANIMALS studies
(Young and old Wistar rats)
ON ANIMALS studies
(Young and old Wistar rats)
PLASMA: Improvement of protein and lipid oxidation markers; Improvement of lipidic profile; Attenuation of hepatic damage markers; Decrease of ROS levels. LIVER: Improvement of protein and lipid oxidation markers; Increase of antioxidant enzymes; Decrease of ROS levels in hepatocytes. LIVER MITOCHONDRIA: Increase of ATP and cytrate synthase levels; Decrease of ROS levels; Increase of mitochondrial respiration rate; Increase of vitamin E levels.
ON HUMANS studies
Subjects started a 30-day supplementation period with the consumption of 500 g of fresh strawberries per day
An improved resistance to hemolysis was observed after 30 days of strawberry supplementation and 15 days after the end of the study
AFTER STRAWBERRY INTAKE
** * * * * * * ** ** ** *
ON HUMANS studies
Subjects started a 2-week supplementation period with the consumption of 500 g of fresh strawberries per day
Significant reduction in DNA damage (Comet assay) of lymphocytes exposed to oxidative stress, after strawberry consumption
AFTER STRAWBERRY INTAKE
ON HUMANS studies
Subjects started a 30-day supplementation period with the consumption of 500 g of fresh strawberries per day AFTER STRAWBERRY INTAKE
A) Resting platelet B) Central clustering platelets C) Degranulated platelets
FRAP ORAC Vit C Uric Acid MDA 8-OHdG Isoprostane LDL-C Total Cholesterol Triglycerides
ON HUMANS studies
Subjects started a 30-day supplementation period with the consumption of 500 g of fresh strawberries per day
Until today, berries in general were considered to be a rich- natural source of bioactive compounds (mainly polyphenols) with antioxidant properties.. …..polyphenols don’t have
- nly antioxidant properties.
They also display other effects, like pro-apoptotic or pro-oxidant effects, that may seem negative but in hyperproliferative cells can have, in turn, positive effects
BUT
IN VITRO studies
N202/1E N202/1A
Treated with different concentrations of strawberries methanolic extracts
Murine mammary tumoral cell lines Cancer cells
No detectable HER 2/neu
- ncoprotein expression
High levels of HER 2/neu
- ncoprotein expression
Cell viability
IN VITRO studies
Apoptosis rate and intracellular ROS concentration after 48 hours of incubation with strawberry methanolic extracts.
Cancer cells Murine mammary tumoral cell lines
IN VITRO studies Cancer cells
Seahorse XF-24 : Glycolysis at different concentrations
- f strawberry extracts
- N202/1E respond to glycolysis inhibitors better than N202/1A;
- Strawberry treatment (for example 3 µg/ml of anthocyanins) is capable to
increase the glycolysis in N202/1E, but decreases glycolysis in N202/1A.
Murine mammary tumoral cell lines
IN VITRO studies Cancer cells Murine line FVB/N 233 neu-NT
Standard diet (AIN93)
AIN93
Standard diet (AIN93)
AIN93
+ Strawberry
I II Sacrifice Time Experimental design
2 months
- ld
6 months
- ld
Day 120 Murine line FVB/N 233 neu-NT
- Kinetics of breast cancer development
- Lung metastases formation
IN VITRO studies Cancer cells Murine line FVB/N 233 neu-NT
Control Strawberr y Control Strawberry Control Strawberr y
Tumor number Tumor volume Tumor free mice
Kinetics of cancer development
IN VITRO studies Cancer cells Murine line FVB/N 233 neu-NT
Lung metastases formation:
- Metastases number
- % mice with metastases
- Metastases size
Could strawberries protect against oxidative damage through direct or Indirect activation of the SIRT 1/PGC 1α/NRF 2 Pathway? Strawberry bioactive compounds
NRF2 nucleus
ARE
SIRT1 Gpx, Gclc, Cat
ROS NFkB?
Inflammation Development of age-related diseases and aging Apoptosis Cellular energetics Cellular function
AMPK
Mitochondrial biogenesis
SIRT1
PGC- 1α
NO NADPH oxidase
TNFα? eNOS ? ?
- f DNA damage
OGG1
Evidences for strawberry health benefits
- Take home messages -
Characterization of the main bioactive compounds and of their antioxidant capacity Strawberry treatment In vitro
- Protection against UV
irradiation in human fibroblasts;
- Improvement of
mitochondrial respiration and glycolysis after H2O2- and AAPH-induced stress in human fibroblasts. In vivo
- Improved resistance
- f erythrocytes to
hemolysis;
- Improvement of
- xidative stress
biomarkers and lipid profile in plasma;
- Reduced DNA
damage in lymphocytes after H2O2-induced stress.
- Inhibition of viability,
increase of apoptosis and intracellular ROS production and impairment of mitochondrial functionality in murine breast cancer cells.
- Protection against
ethanol-induced gastric lesions;
- Reduction of breast
tumor number and volume and lung metastases;
- Improvement of
antioxidant status and mitochondrial functionality against DOX-induced stress.
SOCIAL IMPACT
Many thanks to:
- Prof. Josè L.Quiles
- Prof. Bruno Mezzetti
- Dr. Franco Capocasa
- Dr. Jacopo Diamanti
- Dr. Stefano Bompadre
- Dr. Stefania Romandini
- Dr. Josè M. Alvarez Suarez
- Dr. Francesca Giampieri
- Dr. Massimiliano Gasparrini
- Dr. Tamara Y. Forbes-Hernandez
- Dr. Sara Tulipani
Prof .Celestino Santos Buelga
- Dr. Ana Paramas
Prof .Dragana Dekanski
- Dr. Slavica Ristic
- Dr. Nevena V. Radanjic
- Dr. Natasa D. Petronijevic